Wyndly provides a convenient and affordable way to fix your allergies forever. Wyndly’s doctors train your immune system to ignore its allergy triggers, and their telehealth platform provides 24/7 access to a doctor. Using FDA-approved medicines and telehealth, Wyndly is increasing access to allergy immunotherapy for the 50 million Americans suffering from severe allergies.
Wyndly cofounder Dr. Manan Shah saw that the healthcare system incentivized providing allergy sufferers weekly allergy shots to maximize revenue, even though a more convenient, safer, and affordable treatment existed: oral at-home allergy immunotherapy. Seeing the opportunity for a superior solution for patients, Manan teamed up with his cousin, Aakash, to build a specialty online allergy practice that offered the highest quality care to patients across the country - without asking them to come to an in-person appointment.
Aakash and Manan participated in the Y Combinator Winter 2021 batch, and since graduating have seen exciting revenue growth and patient outcomes. They plan to use this round to fuel growth and double down on new patient outreach efforts.
Y Combinator, Goodwater Capital, Civilization Ventures, Kevin Mahaffey